OPKO Health Inc (OPK)

9.12
NASDAQ : Health Care
Prev Close 9.03
Day Low/High 9.00 / 9.28
52 Wk Low/High 7.12 / 11.85
Avg Volume 3.31M
Exchange NASDAQ
Shares Outstanding 550.38M
Market Cap 4.97B
EPS -0.10
P/E Ratio 31.14
Div & Yield N.A. (N.A)

Latest News

Opko Health (OPK) Stock Higher After Q2 Earnings Beat

Opko Health (OPK) Stock Higher After Q2 Earnings Beat

Opko Health (OPK) posted earnings and revenue that topped analysts' estimates for the 2016 second quarter following Monday's market close.

OPKO Health Reports Improved Financial And Operating Results

OPKO Health Reports Improved Financial And Operating Results

OPKO Health, Inc. (NYSE:OPK), reports financial and operating results for the three and six months ended June 30, 2016.

'Mad Money' Lightning Round: I'm Still With Opko Health

'Mad Money' Lightning Round: I'm Still With Opko Health

Cramer wants you to stick with Abbvie and says Cepheid is working.

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Jim Cramer's 'Mad Money' Recap: Four Winning Themes, Four to Avoid

Cramer has seen enough in this earnings season to come to some conclusions on what's working and what isn't.

OPKO To Announce Second Quarter Operating And Financial Results On August 8, 2016

OPKO To Announce Second Quarter Operating And Financial Results On August 8, 2016

OPKO Health, Inc. (NASDAQ:OPK) will release operating and financial results for the three and six months ended June 30, 2016, after the close of the U.

Opko Is a Buying Opportunity After FDA's Approval of Kidney Drug

Opko Is a Buying Opportunity After FDA's Approval of Kidney Drug

Banking on its Rayaldee treatment, this once-quiet pharmaceutical company has stepped up its investor profile with its first analyst day and a recent move to Nasdaq.

OPKO Health To Acquire Transition Therapeutics

OPKO Health To Acquire Transition Therapeutics

OPKO Health, Inc. (NASDAQ:OPK) and Transition Therapeutics Inc.

Weak On High Volume: Opko Health (OPK)

Weak On High Volume: Opko Health (OPK)

Trade-Ideas LLC identified Opko Health (OPK) as a weak on high relative volume candidate

Opko (OPK) Stock Gains as FDA Approves Rayaldee

Opko (OPK) Stock Gains as FDA Approves Rayaldee

Opko (OPK) stock is up this morning after the FDA approved its drug Rayaldee.

Morning Movers: BAC, MRO, NKE, OPK

Markets are projecting a positive open as Brexit-worries have abated.

'Mad Money' Lightning Round: Buy, Buy, Buy Medtronic

'Mad Money' Lightning Round: Buy, Buy, Buy Medtronic

Cramer sees Micron Technology getting back to $15 and urges caution on Holly Energy Partners.

Jim Cramer's 'Mad Money' Recap: Today's Rally Was Good but We Need More

Jim Cramer's 'Mad Money' Recap: Today's Rally Was Good but We Need More

The markets really need to see the financials, technology and healthcare sectors to move as they make up the bulk of our economy, says Jim Cramer.

OPKO Health To Host Analyst & Investor Day In New York City On June 15

OPKO Health To Host Analyst & Investor Day In New York City On June 15

OPKO Health, Inc. (NYSE:OPK) ("OPKO" or the "Company") announces that it will host an Analyst & Investor Day on Wednesday, June 15, 2016 beginning at 4:30 p.

Opko Health (OPK) Is Today's Strong On High Volume Stock

Opko Health (OPK) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Opko Health (OPK) as a strong on high relative volume candidate

OPKO Health Announces Move To NASDAQ Stock Market

OPKO Health Announces Move To NASDAQ Stock Market

OPKO Health, Inc. (NYSE:OPK) ("OPKO" or the "Company") announces that it will move its stock exchange listing to The NASDAQ Stock Market from The New York Stock Exchange (the "NYSE").

OPKO To Discuss Draft Coverage Determinations For 4Kscore® Test At 2016 Jefferies Healthcare Conference

OPKO To Discuss Draft Coverage Determinations For 4Kscore® Test At 2016 Jefferies Healthcare Conference

OPKO Health, Inc. (NYSE: OPK) today announced that senior management will discuss recent draft local coverage determinations by certain Medicare Administrative Contractors for OPKO's 4Kscore® test at the Jefferies...

OPKO Health To Present At The 2016 Jefferies Healthcare Conference

OPKO Health To Present At The 2016 Jefferies Healthcare Conference

OPKO Health, Inc. (NYSE:OPK) today announced that senior management will present at the Jefferies Healthcare Conference in New York City on Thursday, June 9, 2016 at 11:30 AM (EDT).

OPKO Health Receives Proposed/Draft Medicare Local Coverage Determination For 4Kscore® Test

OPKO Health Receives Proposed/Draft Medicare Local Coverage Determination For 4Kscore® Test

OPKO Health, Inc. (NYSE:OPK) ("OPKO" or the "Company") announces that Novitas Solutions has issued a draft local coverage determination for the 4Kscore ® Test, the only blood test that accurately identifies an...

OPKO Announces Appointment Of Douglass Laidlaw As Vice President Of Medical Affairs

OPKO Announces Appointment Of Douglass Laidlaw As Vice President Of Medical Affairs

OPKO Health, Inc. (NYSE: OPK) today announced the appointment of Douglass Laidlaw, PhD as Vice President of Medical Affairs to support the anticipated launch of RAYALDEE ®.

Biotech Gets a Lifeline

Solid earnings and the start of some M&A activity may be just what this sector needs to rise.

OPKO Announces Appointment Of Thomas Nusbickel As Senior Vice President Of Pharmaceutical Marketing And Market Access

OPKO Announces Appointment Of Thomas Nusbickel As Senior Vice President Of Pharmaceutical Marketing And Market Access

OPKO Health, Inc. (NYSE: OPK) today announced the appointment of Thomas Nusbickel as Senior Vice President of Pharmaceutical Marketing and Market Access to support the anticipated launch of RAYALDEE ®.

OPKO Health Reports First Quarter Financial And Operating Results

OPKO Health Reports First Quarter Financial And Operating Results

OPKO Health, Inc. (NYSE:OPK), a multinational biopharmaceutical and diagnostics company, today reported financial and operating results for the three months ended March 31, 2016.

Vifor Fresenius Medical Care Renal Pharma And OPKO Health Enter Into Agreement For OPKO's RAYALDEE®

Vifor Fresenius Medical Care Renal Pharma And OPKO Health Enter Into Agreement For OPKO's RAYALDEE®

Vifor Fresenius Medical Care Renal Pharma (VFMCRP), a common company of Galenica and Fresenius Medical Care, and OPKO Health (NYSE: OPK), have entered into a collaboration and license agreement for the development and...

OPKO To Announce First Quarter Operating And Financial Results On May 9, 2016

OPKO To Announce First Quarter Operating And Financial Results On May 9, 2016

OPKO Health, Inc. (NYSE: OPK), a multinational biopharmaceutical and diagnostics company, will release operating and financial results for the three months ended March 31, 2016, after the close of the U.

OPKO Presents Additional Data On RAYALDEE® At National Kidney Foundation Spring Clinical Meetings 2016

OPKO Presents Additional Data On RAYALDEE® At National Kidney Foundation Spring Clinical Meetings 2016

OPKO Health, Inc. (NYSE:OPK), announced that additional data on RAYALDEE as a treatment for secondary hyperparathyroidism (SHPT) will be highlighted later today in a poster presentation at the National Kidney Foundation...